Phase 1b/2 Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia
عنوان الدراسة
Phase 1b/2 Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia
داعم الدراسة
Onyx Therapeutics, Inc., an Amgen Inc. Subsidiary
دواء الدراسة
Carfilzomib
رقم بروتوكول الدراسة
20140106
حالة الدراسة
Terminated
موقع الدراسة
King Fahad Medical City (Riyadh)
مرحلة الدراسة
2
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.